Big Gain For Tilray, Inc.
Wed, Feb 10, 2021 at 05:30 PM
Tilray, Inc. (TLRY:NASDAQ) soared at $63.91, a gain of 50.9%. On Tue 09 Feb 21, TLRY:NASDAQ hit a New 2-Week High of $42.35. The stock got featured on our News Catalysts scanner on Wed 10 Feb 21 at 05:07 PM in the 'BIOTECH' category. From Tue 26 Jan 21, the stock recorded 70.00% Up Days and 72.73% Green Days
About Tilray, Inc. (TLRY:NASDAQ)
Tilray Inc is engaged in sale and development of medical cannabis. Geographically, the company derives majority of its revenue from Canada. The product categories of the company include dried cannabis which include whole flower and ground flower,and cannabis extract which include full spectrum and purified oil drops and capsules.
Top 10 Gainers:
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 187.36%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 126.35%
- United States Antimony Corporation (UAMY:NYSEMKT), 82.56%
- Sundial Growers Inc. (SNDL:NASDAQ), 78.79%
- Tengasco, Inc. (TGC:NYSEMKT), 77.19%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 62.19%
- Tilray, Inc. (TLRY:NASDAQ), 50.91%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 50.53%
- AYRO (AYRO:NASDAQ), 50.2%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 49.05%